Integrated Immunogenicity Assessment of a Novel, First-in-Class TrenibotulinumtoxinE Across 5 Clinical Trials for Glabellar Lines

Toxicon 2026

View at publisher

Authors: Steve G. Yoelin, Edward L. Lain, Marion Moers-Carpi, Michael Gold, David Wirta, Wayne Lam, Amy S. Weitzenfeld, Jie Shen, Mitalee Tamhane

DOI: 10.1016/j.toxicon.2025.108913

Cited by: 1

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Intramuscular injections and effects Surgical Sutures and Adhesives